Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, Q2 2026
1,762
Period ended Jun 30, 2026
Change on a year earlier
-149.6%
-3,556 in Q2 2025
History
68 quarters
Since Q3 2008
Sources
60
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Cash Used in Financing Activities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 1,762 | -149.6% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | -2,981 | -48.2% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 4,751 | -257.9% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 2,638 | -208.8% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | -3,556 | -392.4% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | -5,755 | +104.5% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | -3,009 | +34.0% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | -2,425 | -43.2% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,216 | -67.6% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | -2,814 | +37.0% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | -2,245 | +44.5% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | -4,269 | +58.0% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 3,758 | -311.5% | Form 10-Q (filed 2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | -2,054 | -33.4% | Form 10-Q (filed 2023-05-05) ↗ |
| Q4 2022 | Dec 31, 2022 | -1,554 | -129.8% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | -2,702 | +18.8% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | -1,777 | -178.6% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | -3,086 | +47.1% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | 5,207 | +279.5% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | -2,274 | -41.0% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 2,262 | +98.9% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | -2,098 | +40.8% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 1,372 | -168.2% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | -3,851 | +22.2% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 1,137 | -154.6% | Form 10-Q (filed 2020-08-05) ↗ |
| Q1 2020 | Mar 31, 2020 | -1,490 | -7.7% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | -2,011 | -63.9% | Form 10-K (filed 2020-02-26) ↗ |
| Q3 2019 | Sep 30, 2019 | -3,152 | +65.5% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | -2,084 | -29.8% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | -1,614 | -40.7% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | -5,566 | -3.8% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | -1,905 | -455.4% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | -2,967 | -52.3% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | -2,722 | -286.3% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | -5,785 | +192.6% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 536 | -164.2% | SEC Filing ↗ |
| Q2 2017 | Jun 30, 2017 | -6,218 | +84.7% | SEC Filing ↗ |
| Q1 2017 | Mar 31, 2017 | 1,461 | -151.0% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | -1,977 | -17.8% | SEC Filing ↗ |
| Q3 2016 | Sep 30, 2016 | -835 | -67.1% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | -3,366 | -39.9% | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | -2,866 | -155.6% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | -2,406 | -75.4% | SEC Filing ↗ |
| Q3 2015 | Sep 30, 2015 | -2,539 | -298.5% | SEC Filing ↗ |
| Q2 2015 | Jun 30, 2015 | -5,597 | -33.1% | SEC Filing ↗ |
| Q1 2015 | Mar 31, 2015 | 5,155 | +218.2% | Form 10-Q (filed 2015-05-07) ↗ |
| Q4 2014 | Dec 31, 2014 | -9,772 | – | SEC Filing ↗ |
| Q3 2014 | Sep 30, 2014 | 1,279 | -165.8% | Form 10-Q (filed 2014-11-10) ↗ |
| Q2 2014 | Jun 30, 2014 | -8,369 | – | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 31, 2014 | 1,620 | -214.0% | Form 10-Q (filed 2014-05-08) ↗ |
| Q2 2013 | Sep 30, 2013 | -1,945 | +163.6% | Form 10-Q (filed 2013-11-07) ↗ |
| Q1 2013 | Mar 31, 2013 | -1,421 | +96.0% | Form 10-Q (filed 2013-05-09) ↗ |
| Q4 2012 | Dec 31, 2012 | -1,218 | -45.4% | Form 10-K (filed 2013-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | -738 | -67.1% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jun 30, 2012 | -586 | – | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | -725 | – | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | -2,231 | +72.3% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Sep 30, 2011 | -2,244 | +38.1% | Form 10-Q (filed 2011-11-08) ↗ |
| Q4 2010 | Dec 31, 2010 | -1,295 | -30.0% | Form 10-Q (filed 2011-11-08) ↗ |
| Q3 2010 | Sep 30, 2010 | -1,625 | -31.5% | Form 10-Q (filed 2011-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | -3,463 | -216.4% | Form 10-Q (filed 2011-08-08) ↗ |
| Q1 2010 | Mar 31, 2010 | 942 | -340.4% | Form 10-Q (filed 2011-05-09) ↗ |
| Q4 2009 | Dec 31, 2009 | -1,849 | -55.0% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2009 | Sep 30, 2009 | -2,372 | +209.3% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2009 | Jun 30, 2009 | 2,975 | – | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2009 | Mar 31, 2009 | -392 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2008 | Dec 31, 2008 | -4,107 | – | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2008 | Sep 30, 2008 | -767 | – | Form 10-Q (filed 2009-10-29) ↗ |
Cite this data
StockData. (2026). Merck Net Cash Used in Financing Activities ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_cf_fcf_fin
See every metric in the Merck KPI table. Data updated Oct 26, 2026.